Researchers developed an ultra-thin, flexible sensor that can track glucose levels in tears and sweat for improved diabetes monitoring. The biosensor detects a range of glucose concentrations and is flexible enough to be incorporated into contact lenses or watches.
Researchers have demonstrated that electronic modulation of the carotid sinus nerve can restore insulin sensitivity and glucose homeostasis in diabetic rats. The treatment has been shown to be reversible without significant adverse effects. This study provides a promising new approach for managing type 2 diabetes.
A new study from the University of Eastern Finland found that camelina oil reduces overall and LDL cholesterol levels in individuals with impaired glucose metabolism. Camelina oil, rich in alpha-linolenic acid, showed a positive effect on blood cholesterol levels but had no similar effects for fatty or lean fish.
A stress protein found in muscle has been linked to diabetes promotion, but blocking it with inhibitors could prevent glucose intolerance. FKBP51-protein inhibitors are being developed for clinical trials to treat diabetes and metabolic diseases.
Researchers at UCLA discovered that high glucose levels in pregnant women can lead to premature heart cell maturation, increasing the risk of congenital heart disease. The study found that targeting the pentose phosphate pathway could help generate more mature cells for regenerating heart tissue.
Researchers from Ural Federal University and Russian Academy of Sciences developed new methods to treat type 1 diabetes by using anti-diabetic chemical compounds. The study showed that these compounds can help reduce glucose levels and increase insulin production in lab rats with diabetes.
Engineers at UC San Diego developed a smartphone case and app that allows patients to record and track their blood glucose readings anywhere. The device, called GlucPhone, uses reusable sensors and wireless transmission for accurate measurements.
A study published in the Journal of Clinical Endocrinology & Metabolism found that continuous glucose monitors can protect against hypoglycemia episodes, even when the body's defense mechanisms are impaired. The devices raised awareness of low blood sugar threats and reduced severe episodes.
Scientists studied how intestinal epithelial stem cells respond to varying glucose levels, discovering a switch from renewal to growth mode triggered by higher glucose. This finding has implications for understanding cancer cell proliferation and developing new therapeutic strategies.
Experts developed a streamlined approach to using Dexcom G5 Mobile Continuous Glucose Monitor (CGM) trend arrow data. The new tool helps individuals with diabetes adjust insulin doses more accurately, reducing dangerous fluctuations and long-term complications.
Researchers have identified a new blood-sugar marker, fructosamine, that can predict patients at highest risk of complications after joint surgery. The test detects changes in glucose control faster than current markers, which could help prevent life-threatening post-surgery complications.
A genetic variant in ankyrin-B gene causes cells to store more fat, leading to obesity. This variant is carried by millions of Americans and can be identified through family history and physiological traits.
Researchers discover that CDK8 plays a critical role in allowing cancer cells to use glucose for energy. Blocking CDK8 activity combined with glycolysis inhibitors slows cancer cell growth more effectively than either approach alone.
Researchers found a connection between abnormal glucose breakdown in the brain and the severity of Alzheimer's symptoms, with lower glycolysis rates and higher brain glucose levels correlated to more severe pathology. The study suggests that targeting glycolysis defects could lead to new treatments for Alzheimer's disease.
A study published in the Journal of Human Evolution found that humans do not have uniquely expensive brains, challenging a major dogma in human evolution studies. Researchers measured the cross-sectional area of cranial arteries and brain glucose uptake to compare brain costs across 22 species.
A two-week high-intensity interval training (HIIT) program reduced glucose metabolism in all areas of the brain in physically inactive individuals with prediabetes or type 2 diabetes. HIIT improved whole-body insulin sensitivity, and moderate exercise also showed similar benefits.
Scientists at Columbia University Irving Medical Center have identified several compounds that selectively inhibit FOXO1, improving insulin sensitivity and reducing glucose production in the liver. These findings offer a promising approach to developing new, safer treatments for diabetes.
Researchers at the University of Pennsylvania School of Medicine conducted a randomized control trial showing that providing small financial incentives can motivate young people to engage in daily glucose monitoring. Participants who received $60 monthly credits were nearly three times more likely to achieve daily goals, but overall gl...
A new Yale study reveals decreased brain glucose levels in individuals with obesity and type 2 diabetes compared to lean individuals. This finding might explain the underlying mechanisms of disordered eating behavior and an increased risk of Alzheimer's disease among obese and diabetic individuals. The researchers suggest that impaired...
Researchers at NYU School of Medicine discovered that calcium flow into cells controls the activation of genes involved in glucose metabolism, enabling T cells to multiply. The study's findings have implications for autoimmune diseases and may lead to new treatments.
Researchers at Joslin Diabetes Center found that mice on a fatty diet who consumed high levels of fructose suffered worse metabolic effects compared to those given similar calories of glucose. The study highlighted the increased production of an enzyme called Khk, which is specifically important in fructose metabolism.
Researchers at Charité found that retinol saturase plays a role in adaptive processes in liver cells, increasing with body weight and reducing negative metabolic effects associated with excess glucose exposure. The enzyme's inactivation may offer a new approach to treating metabolic liver disease and its related issues.
The new model predicts how glucose-responsive insulin (GRI) will affect patients' blood sugar levels based on chemical traits. The MIT team identified several strong GRI candidates and plans to test them in animals.
Researchers at Joslin Diabetes Center identified PKC-delta as a natural protective factor that works against chronic inflammation in diabetes, which can lead to cardiovascular disease. The study found that PKC-delta suppresses the population of macrophages and inhibits a biological pathway that protects cells from dying.
EPFL scientists have discovered metabolic differences between hepatoblastoma subtypes and identified biomarkers to aid in more accurate subtyping. The study reveals that embryonal hepatoblastoma cells use glucose and are sensitive to its metabolism, offering a new approach for personalized treatment.
Researchers at Binghamton University have created a wearable, single-use biosensor that integrates a paper-based glucose/oxygen enzymatic fuel cell into a standard Band-Aid adhesive patch. This device allows for non-invasive monitoring of glucose in human sweat during exercise, providing an attractive alternative to conventional methods.
A new trial found that continuous glucose monitoring during pregnancy reduces the number of babies born larger than average, need for intensive care, and pre-eclampsia rates. Birth outcomes improved significantly for mothers using the device compared to traditional finger-prick tests.
A recent study published in the Journal of Biological Chemistry found that specific sugars attached to a key protein called Notch can serve as quality-control markers, ensuring its proper transport to the cell membrane. This discovery has implications for understanding cancer progression and developing potential treatments.
New research suggests that eating six meals per day improves blood sugar control and reduces hunger in obese individuals with impaired glucose tolerance or type 2 diabetes. The study found that the six-meal plan decreased glycated haemoglobin levels, post-oral glucose tolerance test blood glucose levels, and abnormally high insulin lev...
A recent study suggests that consuming large amounts of artificial sweeteners can alter the body's response to glucose, increasing the risk of developing type 2 diabetes. The study found that just two weeks of supplementation with artificial sweeteners was enough to enhance glucose absorption and increase blood glucose levels.
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes. Patients experienced a lower rate of confirmed severe hypoglycemia than observed in patients on placebo and also had weight loss.
Researchers have identified a key molecular connection between inflammation and insulin resistance in type 2 diabetes. The discovery sheds light on how chronic inflammation increases the risk of developing insulin resistance, which can lead to full-blown diabetes.
Research suggests sugary drinks can lead to leptin resistance in rats, causing them to overeat and gain weight. This phenomenon may also apply to humans, highlighting the potential dangers of frequent sugary drink consumption.
A new approach uses a polymer sponge implanted in fat tissue to reduce weight gain and blood-sugar levels in obese mice. The treatment, which 'gets the fat to talk' again, shows promise as a simpler alternative to current diabetes treatments.
A phase 3 trial found that biosimilar insulin lispro (SAR342434) has comparable efficacy and safety to Humalog in adults with type 1 diabetes. The study's findings support the use of biosimilars as a cost-effective alternative for insulin treatment.
Researchers found that glucose metabolism is critical for platelet production, function, and clearance. The absence of glucose metabolism leads to lower platelet counts, defective megakaryocyte generation, and increased platelet clearance.
Research examines how gastric emptying rates affect postprandial glucose levels and incretin hormone secretion. The study reveals the gastrointestinal tract's contribution to insulin regulation in individuals with type 2 diabetes.
A recent survey of primary care physicians found that nearly two-thirds could not correctly identify all risk factors for prediabetes. The study highlights the need for increased provider knowledge and availability of resources to help patients reduce their risk of developing type 2 diabetes.
Researchers have discovered a novel mechanism by which AMPK senses glucose levels, enabling the switch to alternative fuels. This breakthrough has significant potential for understanding and treating diabetes.
Researchers at Arizona State University have developed a new approach to convert biomass into renewable biofuels and chemicals, using the trial-and-error power of evolution. By harnessing this power, they were able to coax bacteria to better ferment sugars derived from biomass, leading to a 50% increase in product yield.
Researchers at UT Dallas developed a wearable diagnostic tool that measures cortisol, glucose and interleukin-6 in perspired sweat for up to a week, enabling continuous health tracking. The device uses room temperature ionic liquid to stabilize the microenvironment, making it practical and affordable.
Scientists have successfully employed a novel type of imaging that uses glucose metabolism activity to identify solid tumors or aggressively growing areas. This method, called magnetization transfer effect, allows for the visualization of changes in glucose levels in brain tissue without the need for radioactivity.
Research published in Mayo Clinic Proceedings found that critically ill patients with dysglycemia have higher mortality rates, and that a target glucose level of 80-140 mg/dL is associated with best prospects for survival. The study suggests that broader glucose control protocols from admission to discharge may improve survivability.
Researchers at Instituto Gulbenkian de Ciência found that controlling iron levels is crucial for maintaining vital organs' function during infection. They discovered ferritin's role in regulating glucose production, which prevents lethal sepsis outcomes.
Researchers at Kanazawa University found that transcranial direct current stimulation (tDCS) on the lateral occipito-temporal cortex (LOTC) improved mental manipulation of body part imagery. This improvement was observed in healthy adults, indicating potential benefits for exercise learning and rehabilitation outcomes.
Researchers found that HbA1C levels are higher in blacks compared with whites for a given mean glucose level, suggesting racial differences in glycation of hemoglobin. This discrepancy highlights the need for clinicians to individualize care based on blood glucose levels rather than relying solely on HbA1C levels.
Researchers found that participants with higher fasting plasma glucose levels lost more weight on a high-fiber, low-glycemic diet compared to those with lower blood sugar levels. Participants with high fasting blood glucose had lost an average of 9.4% body weight, while those with low fasting blood glucose had lost 4.1%.
Recent clinical studies support the value of continuous glucose monitoring (CGM) in reducing blood glucose variability and improving patient quality of life. CGM has been shown to be safe and effective, with regulatory approval for nonadjunctive use representing a major advance.
Researchers have developed a novel approach to detecting dengue infection using PET-FDG imaging, which tracks glucose uptake and predicts disease progression. This non-invasive method has the potential to transform the assessment of new treatments in clinical trials.
Researchers at Duke University have created a technology that fuses GLP1 with a heat-sensitive elastin-like polypeptide, providing glucose control up to three times longer than current treatments. The new biopolymer injection lasts more than two weeks in primates and has the potential to replace daily or weekly insulin shots.
The article provides recommendations to standardize continuous glucose monitoring (CGM) in clinical trials, improve glycemic control, and reduce risks of hypoglycemia. The authors suggest better data collection and analysis techniques to maximize the benefits of CGM in diabetes research.
The approved flash glucose monitoring system provides accurate data on demand, reducing the need for calibration, and offers a clinical benefit for individuals with type 1 diabetes. The technology has been shown to improve insulin dosing and overall glycemic control.
Scientists at Trinity College Dublin discovered that dendritic cells become better at stimulating T lymphocytes when starved of glucose. This finding opens the door to developing new therapies for debilitating immune-related diseases.
Researchers at the University of Iowa discovered a protein that controls glucose uptake in fat cells based on cell swelling, leading to insights into the relationship between obesity and type 2 diabetes. Mice lacking this protein developed insulin resistance and glucose intolerance despite having smaller fat cells.
Researchers have made significant progress in understanding the structure of the glucagon receptor, a key component in glucose regulation. The study provides detailed molecular information that can guide the development of more accurate and efficient diabetes drugs.
A new technique uses modified insulin and red blood cells to regulate blood sugar levels in mice with Type 1 diabetes. The system effectively reduces blood sugar levels for 48 hours and has shown promise in reducing the risk of hypoglycemia.
Salk Institute scientists discover a chemical compound that mimics exercise benefits, increasing fat burning and stamina in sedentary mice. The compound, GW1516, activates a gene pathway linked to aerobic endurance, allowing mice to run for 70% longer than controls.
Researchers found that brain glucose levels play a crucial role in 'hitting the wall,' and training can help preserve glucose as an energy source for the brain. A small molecule drug also stimulated PPARδ, increasing fat oxidation and preventing hypoglycemia in mice.
Researchers developed a personalized algorithm that predicts the impact of particular foods on an individual's blood sugar levels. The Glucoracle app allows users to upload food and blood measurements, providing real-time predictions of post-meal blood sugar levels.
Researchers developed a personalized algorithm that predicts the impact of specific foods on an individual's blood sugar levels. The algorithm has been integrated into an app, Glucoracle, allowing individuals with type 2 diabetes to make better nutritional choices.